相关实验视频

Updated: Jun 16, 2026

Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis

Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis

Published on: January 29, 2016

多发性硬化症全身冷刺激:一个范围审查

Angelo Alito¹, Jacopo Maria Fontana², Eleonora Franzini Tibaldeo³

¹Department of Biomedical, Dental Sciences and Morphological and Functional Images, University of Messina, 98125 Messina, Italy.

Journal of clinical medicine

|April 13, 2024

概括

全身冷刺激 (WBC) 可能通过减少疲劳和改善幸福感,为多发性硬化症 (MS) 患者提供短期益处. 这种冷疗法显示出作为辅助治疗的潜力,没有报告的不良影响.

科学领域:

神经学神经学
物理疗法物理治疗
免疫学免疫学免疫学

背景情况:

多发性硬化症 (MS) 是年轻成年人非创伤性长期残疾的主要原因.
全身冷刺激 (WBC) 涉及暴露在冷温度 (≤-110°C) 中2-3分钟.
WBC诱导生理变化模仿运动在多个身体系统.

研究的目的:

审查WBC作为MS辅助疗法的潜在作用.
评估WBC对MS患者各种生理和心理参数的影响.

主要方法:

文学范围审查. 文学范围审查.
在PubMed,ScienceDirect,Embase和Web of Science数据库中搜索到2023年11月30日.
包括13篇相关文章.

主要成果:

在MS中,WBC可能会提供短期的抗氧化益处.
在抗氧化酶,氧化,金属蛋白酶,血液细胞计数,风病学或生物化学方面没有观察到显著的变化.
在减轻疲劳,功能状态和精神/身体健康方面注意到显著的改善.
没有报告任何不良影响.

结论:

白血球显示出作为多发性硬化症的补充疗法的潜力.
低温冷刺激可能会激活抗氧化过程.
在MS患者中,WBC可以改善功能状态,情绪,焦虑和疲劳.

关键词:

寒冷疗法治疗的方法通过冷刺激进行冷刺激.多发性硬化症多发性硬化症神经系统疾病神经系统疾病康复康复康复康复康复康复全身冷刺激全身冷刺激

更多相关视频

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

Published on: December 26, 2015

Non-invasive Assessments of Subjective and Objective Recovery Characteristics Following an Exhaustive Jump Protocol

Non-invasive Assessments of Subjective and Objective Recovery Characteristics Following an Exhaustive Jump Protocol

Published on: June 8, 2017

相关概念视频

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...